News Release(2016)

2016
-
December 15, 2016
Announcement of an Agreement for the Co-Promotion of an immunosuppressant Imuran®Tablets 50 mg
-
October 28, 2016
Japanese NDA for an ulcerative colitis treatment agent (Development code: AJG511) was filed.
-
August 9, 2016
Kissei and JCR to Initiate a Phase III Clinical Trial of a Long-Acting Erythropoiesis-Stimulating Agent (Development Code: JR-131)
-
June 16, 2016
Announcement of the Launch of Glufast ®OD Tab. (Orally Disintegrating Tablets)
-
May 27, 2016
Announcement of Additional Clinical Trial of "KPS-0373 (Development Code)" for the Treatment of Spinocerebellar Ataxia
-
March 30, 2016
Kissei and Kyorin signed an Agreement for Co-Development and Co-Marketing of KRP-114V
-
January 15, 2016
Announcement of the Launch of Urief® OD Tab. (Orally Disintegrating Tablets) for the Treatment of Dysuria Associated with Benign Prostatic Hyperplasia in Japan